Biolitec India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 29-07-2024
- Paid Up Capital ₹ 0.10 M
as on 29-07-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.90 M
as on 29-07-2024
- Revenue 27.04%
(FY 2023)
- Profit -53.89%
(FY 2023)
- Ebitda -98.36%
(FY 2023)
- Net Worth 10.82%
(FY 2023)
- Total Assets 1.24%
(FY 2023)
About Biolitec India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.90 M.
Sreetama Kar and Preeti Lodha serve as directors at the Company.
- CIN/LLPIN
U33119KA2007PTC041808
- Company No.
041808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biolitec India Private Limited offer?
Biolitec India Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Optical, Laser Instruments & Devices, Medical Lasers, Surgical & ICU Equipments, Medical Equipment & Accessories.
Who are the key members and board of directors at Biolitec India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreetama Kar  | Additional Director | 17-Nov-2023 | Current |
| Preeti Lodha | Director | 05-Dec-2017 | Current |
Financial Performance of Biolitec India.
Biolitec India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.04% increase. The company also saw a substantial fall in profitability, with a 53.89% decrease in profit. The company's net worth Soared by an impressive increase of 10.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biolitec India?
In 2023, Biolitec India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biolitec Meditech India Private LimitedActive 1 year 7 monthsSreetama Kar and Preeti Lodha are mutual person
Advanced Clinical Research Private LimitedActive 20 years 8 monthsSreetama Kar and Preeti Lodha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Dec 2023 | ₹6.90 M | Open |
How Many Employees Work at Biolitec India?
Biolitec India has a workforce of 23 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolitec India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolitec India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
